CRISPR/Cas9-mediated genomic deletion of the beta-1, 4 nacetylgalactosaminyltransferase 1 gene in murine P19 embryonal carcinoma cells results in low sensitivity to botulinum neurotoxin type C

  • Kentaro Tsukamoto
  • , Chikako Ozeki
  • , Tomoko Kohda
  • , Takao Tsuji

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CRISPR/Cas9-mediated genomic deletion of the beta-1, 4 nacetylgalactosaminyltransferase 1 gene in murine P19 embryonal carcinoma cells results in low sensitivity to botulinum neurotoxin type C'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science